ScripSun signaled launch action ahead in the US and a change in plan for certain pipeline specialty assets, even as it awaits, like other industry peers , more clarity on details around US President Don
ScripLeo Pharma has posted a strong set of financials for the first quarter of 2025, “building on build on the momentum that we delivered in 2024,” CEO Christophe Bourdon has told Scrip . Revenues rose by
ScripAlmirall CEO Carlos Gallardo has added his voice to calls by leaders in the pharmaceutical industry for Europe to create a more innovation-friendly environment before it slips even further behind the
ScripThese are interesting times for Almirall and CEO Carlos Gallardo believes the Spanish firm holds “a unique position as the only company that focuses exclusively on medical dermatology and has capabili